tradingkey.logo

Champions Oncology Inc

CSBR
7.220USD
0.000
收盤 12/19, 16:00美東報價延遲15分鐘
99.55M總市值
33.44本益比TTM

Champions Oncology Inc

7.220
0.000

關於 Champions Oncology Inc 公司

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Champions Oncology Inc簡介

公司代碼CSBR
公司名稱Champions Oncology Inc
上市日期Nov 30, 1988
CEOBrainin (Robert)
員工數量213
證券類型Ordinary Share
年結日Nov 30
公司地址One University Plaza,
城市HACKENSACK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07601
電話12018088400
網址https://championsoncology.com
公司代碼CSBR
上市日期Nov 30, 1988
CEOBrainin (Robert)

Champions Oncology Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+9.81%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+77.99%
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+9.81%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+77.99%
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--

收入明細

FY2026Q1
FY2025
FY2025Q3
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
13.99M
0.00%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Battery Management Corp
17.44%
New Enterprise Associates (NEA)
12.34%
Ackerman (Joel)
7.61%
West Elk Capital, LLC
6.36%
Morris (Ronnie)
6.19%
其他
50.07%
持股股東
持股股東
佔比
Battery Management Corp
17.44%
New Enterprise Associates (NEA)
12.34%
Ackerman (Joel)
7.61%
West Elk Capital, LLC
6.36%
Morris (Ronnie)
6.19%
其他
50.07%
股東類型
持股股東
佔比
Individual Investor
26.67%
Investment Advisor
23.00%
Venture Capital
12.34%
Hedge Fund
7.84%
Investment Advisor/Hedge Fund
3.88%
Research Firm
0.20%
其他
26.06%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
61
6.56M
52.08%
--
2025Q3
62
6.56M
52.44%
-79.02K
2025Q2
63
6.67M
52.80%
-161.89K
2025Q1
63
6.82M
51.27%
-269.97K
2024Q4
54
6.61M
53.30%
-64.85K
2024Q3
52
6.72M
54.61%
-200.66K
2024Q2
56
5.89M
46.40%
+140.55K
2024Q1
56
5.75M
45.40%
-421.54K
2023Q4
54
5.73M
45.75%
-128.46K
2023Q3
60
6.95M
52.42%
-72.37K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Battery Management Corp
2.40M
17.39%
-23.97K
-0.99%
Aug 22, 2025
New Enterprise Associates (NEA)
1.71M
12.43%
--
--
Jun 30, 2025
Ackerman (Joel)
962.13K
6.98%
--
--
Aug 22, 2025
West Elk Capital, LLC
882.58K
6.4%
-210.81K
-19.28%
Sep 30, 2024
Morris (Ronnie)
858.88K
6.23%
--
--
Aug 22, 2025
Sidransky (David)
767.04K
5.56%
--
--
Aug 22, 2025
Pessin (Norman H)
742.16K
5.38%
--
--
Aug 22, 2025
The Vanguard Group, Inc.
327.03K
2.37%
+19.16K
+6.22%
Jun 30, 2025
Tocqueville Asset Management LP
399.88K
2.9%
--
--
Jun 30, 2025
Mendelson (Daniel Newman)
198.63K
1.44%
--
--
Aug 22, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
佔比0.01%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Champions Oncology Inc的前五大股東是誰?

Champions Oncology Inc的前五大股東如下:
Battery Management Corp
持有股份:2.40M
佔總股份比例:17.39%。
New Enterprise Associates (NEA)
持有股份:1.71M
佔總股份比例:12.43%。
Ackerman (Joel)
持有股份:962.13K
佔總股份比例:6.98%。
West Elk Capital, LLC
持有股份:882.58K
佔總股份比例:6.40%。
Morris (Ronnie)
持有股份:858.88K
佔總股份比例:6.23%。

Champions Oncology Inc的前三大股東類型是什麼?

Champions Oncology Inc 的前三大股東類型分別是:
Battery Management Corp
New Enterprise Associates (NEA)
Ackerman (Joel)

有多少機構持有Champions Oncology Inc(CSBR)的股份?

截至2025Q4,共有61家機構持有Champions Oncology Inc的股份,合計持有的股份價值約為6.56M,占公司總股份的52.08% 。與2025Q3相比,機構持股有所增加,增幅為-0.35%。

哪個業務部門對Champions Oncology Inc的收入貢獻最大?

在FY2026Q1,--業務部門對Champions Oncology Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI